A tumor-specific splicing variant of macrophage receptor with collagenous structure (MARCO) promotes metabolic dysregulation resulting in a hypoxic tumor microenvironment by regulating the HIF-1α signaling [15]. This evidence concerns the gene HIF1A and neoplasm.